Michael Pellini, MD

Next-Generation Sequencing:

An Interview with Michael J. Pellini, MD, of Foundation Medicine

February 2013, Vol 2, No 1 - Interview with the Innovators

As the molecular drivers of cancer are better understood and targeted therapies are developed against those drivers, there is a growing need to perform comprehensive molecular analysis of tumors to determine the optimal treatment strategy for each patient. To this end, Foundation Medicine was founded in April 2010 by leaders [ Read More ]